Actually, I don't see how they can get through phase I without seeing efficacy results in addition to safety. It either gets rid of the flu or it doesn't. It won't be a long oncology trial. And, you are correct about a partnership. The curing of the flu will bring the larger pharma's to the table.
In Reply to 'BIzzy' They get through phase ll there will be a partnership and you already know that...don't have the time or inclination to list the myriad examples of that circumstance occurring in the biotech sector
Market Data 
Markets 
AI
